MalBiotics' AntiByotek®

Drug Regimen Data

MalBiotics' AntiByotek® has been meticulously designed to meet the following criteria:

• 7 Day Drug Implementation: Our regimen ensures a treatment duration of 7 days, allowing the patient to adapt to the drug to ensure maximum effectiveness
• Low Parasite Resistance: Through extensive research and testing, we've developed a drug formula with around 20% parasite resistance, ensuring effective treatment.
• Cost Efficiency: Keeping costs low is essential. Our regimen aims for a treatment cost of less than $2000 per 1000 doses, making it accessible to a wider population. Our treatment ended up costing around $2200 for 1000 doses, so not far off from our goal.
• Decrease in Total Parasite Population: Our drug regimen not only targets malaria parasites effectively but also ensures no increase in the parasite population, contributing to long-term disease control.
• Low Side Effects: Patient safety is paramount. We've prioritized minimizing side effects, aiming for mild or moderate reactions to ensure a comfortable enough treatment experience.

About Drug Resistence: Malaria drug resistance surfaces when malaria parasites mutate, making earlier drugs less effective. This makes treatments ineffective and stops disease control efforts. Combatting resistance requires development of new drugs, and good prevention measures. Our careful testing and research process have led to the development of a regimen that excels in these areas, providing a solution in the fight against malaria.